Decreased catecholamine degradation associates with shock and kidney injury after cardiac surgery

Journal of the American Society of Nephrology

Volumn 20, Issue 6, 2009, Pages 1393-1403

  Haase Fielitz, Anja ^a,b   Haase, Michael ^a,b   Bellomo, Rinaldo ^a   Lambert, Gavin ^c   Matalanis, George ^a   Story, David ^a   Doolan, Laurie ^a   Buxton, Brian ^a   Gutteridge, Geoff ^a   Luft, Friedrich C ^d   Schunck, Wolf Hagen ^d   Dragun, Duska ^b,e  

^a AUSTIN HEALTH   (Australia)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^e DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; APROTININ; CATECHOL METHYLTRANSFERASE; CATECHOLAMINE; FUROSEMIDE; METHIONINE; MILRINONE; NORADRENALIN; VALINE;

AGED; AMINO ACID SUBSTITUTION; ARTICLE; CATABOLISM; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE DEPLETION; CATECHOLAMINE METABOLISM; CLINICAL TRIAL; CODON; CONTROLLED STUDY; ENZYME ACTIVITY; EXON; FEMALE; GENETIC ANALYSIS; HEART SURGERY; HETEROZYGOTE; HOMOZYGOTE; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; KIDNEY INJURY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUCLEOTIDE SEQUENCE; POPULATION; POPULATION RESEARCH; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RISK FACTOR; SHOCK;

EID: 67449085975     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2008080915     Document Type: Article

References (49)

1. Mekontso-Dessap A, Houel R, Soustelle C, Kirsch M, Thébert D, Loisance DY: Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function. Ann Thorac Surg 71: 1428-1432, 2001 (Pubitemid 32452519)
2. Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, Bauer P, Hiesmayr M: Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: Prospective cohort study. J Am Soc Nephrol 15: 1597-1605, 2004 (Pubitemid 38679685)
3. Benedict CR, Rose JA: Arterial norepinephrine changes in patients with septic shock. Circ Shock 38: 165-172, 1992
4. Landry DW, Oliver JA: The pathogenesis of vasodilatory shock. N Engl J Med 345: 588-595, 2001
5. Day TA, Randle JC, Renaus LP: Opposing alpha- and beta-adrenergic mechanisms mediate dose-dependent actions of noradrenaline on supraoptic vasopressin neurones in vivo. Brain Res 358: 171-179, 1985 (Pubitemid 16184087)
6. Axelrod J, Tomchick R: Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem 233: 702-705, 1958
7. Weinshilboum RM, Raymond FA: Inheritance of low erythrocyte catechol- o-methyltransferase activity in man. Am J Hum Genet 29: 125-135, 1977 (Pubitemid 8070429)
8. Floderus Y, Ross SB, Wetterberg L: Erythrocyte catechol-O- methyltransferase activity in a Swedish population. Clin Gene 19: 389-392, 1981
9. Zhu BT: Catechol-O-Methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: Importance in pathophysiology and pathogenesis. Curr Drug Metab 3: 321-349, 2002 (Pubitemid 34625043)
10. Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, Xu Y, Koeppe RA, Stohler CS, Goldman D: COMT val158met genotype affects muopioid neurotransmitter responses to a pain stressor. Science 299: 1240-1243, 2003 (Pubitemid 36237467)
11. Voutilainen S, Tuomainen TP, Korhonen M, Mursu J, Virtanen JK, Happonen P, Alfthan G, Erlund I, North KE, Mosher MJ, Kauhanen J, Tiihonen J, Kaplan GA, Salonen JT: Functional COMT Val158Met polymorphism, risk of acute coronary events and serum homocysteine: The Kuopio Ischaemic Heart Disease Risk Factor study. PLoS ONE 2: e181, 2007
12. Happonen P, Voutilainen S, Tuomainen TP, Salonen JT: Catechol-o- methyltransferase gene polymorphism modifies the effect of coffee intake on incidence of acute coronary events. PLoS ONE 1: e117, 2006
13. Meister B, Bean AJ, Aperia A: Catechol-O-methyltransferase mRNA in the kidney and its appearance during ontogeny. Kidney Int 44: 726-733, 1993 (Pubitemid 23290513)
14. Bellomo R, Wan L, May C: Vasoactive drugs and acute kidney injury. Crit Care Med 36: S179-186, 2008
15. Rosner MH, Okusa MD: Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol 1: 19-32, 2006
16. Cryer PE: Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system. N Engl J Med 303: 436-444, 1980 (Pubitemid 10043641)
17. Eisenhofer G, Finberg JP: Different metabolism of norepinephrine and epinephrine by catechol-O-methyltransferase and monoamine oxidase in rats. J Pharmacol Exp Ther 268: 1242-1251, 1994 (Pubitemid 24100338)
18. Best JD, Halter JB: Release and clearance rates of epinephrine in man: Importance of arterial measurements. J Clin Endocrinol Metab 55: 263-268, 1982 (Pubitemid 13238724)
19. Doyle AE, Goodman JE, Silber PM, Yager JD: Catechol-O-methyltransferase low activity genotype (COMTLL) is associated with low levels of COMT protein in human hepatocytes. Cancer Lett 214: 189-195, 2004 (Pubitemid 39207980)
20. Eisenhofer G, Goldstein DS, Stull R, Keiser HR, Sunderland T, Murphy DL, Kopin IJ: Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem 32: 2030-2033, 1986 (Pubitemid 17029190)
21. Sundberg S, Scheinin M, Illi A, Akkila J, Gordin A, Keränen T: The effects of the COMT inhibitor entacapone on haemodynamics and peripheral catecholamine metabolism during exercise. Br J Clin Pharmacol 36: 451-456, 1993 (Pubitemid 23344155)
22. Axelrod J, Albers W, Clemente CD: Distribution of catechol-O- methyltransferase in the nervous system and other tissues. J Neurochem 5: 68-72, 1959
23. Stokes AH, Hastings TG, Vrana KE: Cytotoxic and genotoxic potential of dopamine. J Neurosci Res 55: 659-665, 1999 (Pubitemid 29173480)
24. Bolton JL, Trush MA, Penning TM, Dryhurst G, Monks TJ: Role of quinones in toxicology. Chem Res Toxicol 13: 135-160, 2000 (Pubitemid 30169958)
25. Bindoli A, Rigobello MP, Deeble DJ: Biochemical and toxicological properties of the oxidation products of catecholamines. Free Radic Biol Med 13: 391-405, 1992
26. Macarthur H, Westfall TC, Riley DP, Misko TP, Salvemini D: Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock. Proc Natl Acad Sci USA 97: 9753-9758, 2000 (Pubitemid 30650848)
27. Forsberg MM, Juvonen RO, Helisalmi P, Leppänen J, Gogos JA, Karayiorgou M, MännistöPT: Lack of increased oxidative stress in catechol-O-methyltransferase (COMT)-deficient mice. Naunyn Schmiedebergs Arch Pharmacol 370: 279-289, 2004 (Pubitemid 40063827)
28. Kuroko Y, Fujii T, Yamazaki T, Akiyama T, Ishino K, Sano S, Mori H: Contribution of catechol O-methyltransferase to the removal of accumulated interstitial catecholamines evoked by myocardial ischemia. Neurosci Lett 388: 61-64, 2005 (Pubitemid 41206732)
29. Brandin L, Bergström G, Manhem K, Gustafsson H: Oestrogen modulates vascular adrenergic reactivity of the spontaneously hypertensive rat. J Hypertens 21: 1695-1702, 2003 (Pubitemid 37076353)
30. , Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, Pfaff D, Karayiorgou M: Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci USA 95: 9991-9996, 1998 (Pubitemid 28415282)
31. Helkamaa T, MännistöPT, Rauhala P, Cheng ZJ, Finckenberg P, Huotari M, Gogos JA, Karayiorgou M, Mervaala EM: Resistance to salt-induced hypertension in catechol-O-methyltransferase-gene-disrupted mice. J Hypertens 21: 2365-2374, 2003 (Pubitemid 38293577)
32. Eklöf AC, Holtbäck U, Sundelöf M, Chen S, Aperia A: Inhibition of COMT induces dopamine-dependent natriuresis and inhibition of proximal tubular Na+,K+-ATPase. Kidney Int 52: 742-747, 1997 (Pubitemid 27402374)
33. Xu J, Li G, Wang P, Velazquez H, Yao X, Li Y, Wu Y, Peixoto A, Crowley S, Desir GV: Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J Clin Invest 115: 1275-1280, 2005 (Pubitemid 40629046)
34. Zhao Q, Fan Z, He J, Chen S, Li H, Zhang P, Wang L, Hu D, Huang J, Qiang B, Gu D: Renalase gene is a novel susceptibility gene for essential hypertension: A two-stage association study in northern Han Chinese population. J Mol Med 85: 877-885, 2007 (Pubitemid 47077106)
35. Hix JK, Thakar CV, Katz EM, Yared JP, Sabik J, Paganini EP: Effect of off-pump coronary artery bypass graft surgery on postoperative acute kidney injury and mortality. Crit Care Med 34: 2979-2983, 2006 (Pubitemid 44808741)
36. Goudeau JJ, Clermont G, Guillery O, Lemaire-Ewing S, Musat A, Vernet M, Vergely C, Guiguet M, Rochette L, Girard C: In high-risk patients, combination of antiinflammatory procedures during cardiopulmonary bypass can reduce incidences of inflammation and oxidative stress. Cardiovasc Pharmacol 49: 39-45, 2007 (Pubitemid 46184330)
37. Oliver WC Jr., Nuttall GA, Orszulak TA, Bamlet WR, Abel MD, Ereth MH, Schaff HV: Hemofiltration but not steroids results in earlier tracheal extubation following cardiopulmonary bypass: A prospective, randomized double-blind trial. Anesthesiology 101: 327-339, 2004 (Pubitemid 38988488)
38. Ozal E, Kuralay E, Yildirim V, Kilic S, Bolcal C, Kücükarslan N, Günay C, Demirkilic U, Tatar H: Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery. Ann Thorac Surg 79: 1615-1619, 2005 (Pubitemid 40614576)
39. Morales DL, Garrido MJ, Madigan JD, Helman DN, Faber J, Williams MR, Landry DW, Oz MC: A double-blind randomized trial: Prophylactic vasopressin reduces hypotension after cardiopulmonary bypass. Ann Thorac Surg 75: 926-930, 2003 (Pubitemid 36298370)
40. Lachman HM, Papolos DF, SaitoT, Yu YM, Szumlanski CL, Weinshilboum RM: Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6: 243-250, 1996 (Pubitemid 26226317)
41. Palmatier MA, Kang AM, Kidd KK: Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biol Psychiatry 46: 557-567, 1999 (Pubitemid 29370449)
42. Boudikova B, Szumlanski C, Maidak B, Weinshilboum R: Human liver catechol-O-methyltransferase pharmacogenetics. Clin Pharmacol Ther 48: 381-389, 1990 (Pubitemid 20362271)
43. Qian Q, Wang Y, Zhou R, Li J, Wang B, Glatt S, Faraone SV: Family-based and case-control association studies of Catechol-O-Methyltransferse in attention deficit hyperactivity disorder suggest genetic sexual dimorphism. Am J Med Genet B Neuropsychiatr Genet 118: 103-109, 2003 (Pubitemid 37064084)
44. Eisenhofer G, Friberg P, Rundqvist B, Quyyumi AA, Lambert G, Kaye DM, Kopin IJ, Goldstein DS, Esler MD: Cardiac sympathetic nerve function in congestive heart failure. Circulation 93: 1667-1676, 1996 (Pubitemid 26131343)
45. Argenziano M, Chen JM, Choudhri AF, Cullinane S, Garfein E, Weinberg AD, Smith CR Jr., Rose EA, Landry DW, Oz MC: Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg 116: 973-980, 1998 (Pubitemid 28553541)
46. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, Van Lente F: Expressing the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 53: 766-772, 2007 (Pubitemid 46580250)
47. Kuitunen A, Vento A, Suojaranta-Ylinen R, PettiläV: Acute renal failure after cardiac surgery: Evaluation of the RIFLE classification. Ann Thorac Surg 81: 542-546, 2006 (Pubitemid 43120552)
48. Hosmer DW, Lemeshow S: Assessing the fit of the model. In Applied Logistic Regression (second ed). New York, John Wiley & Sons, 2000, pp 143-202
49. Abdi, H (2007). Bonferroni and Sidak corrections for multiple comparisons, in N.J Salkind (ed.): Encyclopedia of Measurement and Statistics. Thousand Oaks, CA: Sage.